12:30 – 13:10 |
ESTI guidelines : definition of positive negative and indeterminate results, follow-up intervals
Mathias Prokop, Nijmegen/NL
|
13:10 – 13:50 |
Incidental findings: what could be and what should be reported
Annemiek Snoeckx, Antwerp/BE
|
13:50 – 14:30 |
Role of AI in lung cancer screening
Fergus Gleeson, Oxford/UK
|
14:30 – 15:00 |
Q&A
|
15:00 – 15:30 |
Break
|
15:30 – 16:10 |
An overview of ongoing programs in Europe, the SOLACE project
Hans Ulrich Kauczor, Heidelberg /DE
|
16:10 – 16:50 |
Is there a role for biomarkers?
Joanna Chorostowska Varsaw/PO
|
16:50 – 17:30 |
Case-Based Session
Anna Kerpel-Fronius, Budapest/HU
|
17:30 – 18:00 |
Q&A Session
|